RZV Vaccine (Shingrix ®)
2 clinical trials · Condition
◉ Watch RZV Vaccine (Shingrix ®)
| Record | Firm | Date |
|---|---|---|
| Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies (NCT07534007) | Fondazione IRCCS Policlinico San Matteo di Pavia | 2026-02-24 |
| Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls (NCT05575830) | Calmy Alexandra | 2022-12-14 |
Track RZV Vaccine (Shingrix ®) automatically
Every clearance here is in the API, with alerts when new ones post.